Brian O Mahony/X
Nov 4, 2025, 09:17
HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, posted on X.
” The first of our HaemophiliaIRL series of 6 clinical webinars has just started.
This evenings topic: New Therapeutic Possibilities for von Willebrand Disease.
Speaker is Prof. David Lillicrap from Canada. All who registered will recieve a specific e -zine and link to recording.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand
-
Aug 26, 2026, 13:54Giuseppe Biondi Zoccai: Congratulations to the Next Editor-in-Chief of the EHJ
-
Aug 26, 2026, 13:25Omar Adwan: Abnormal Nuclear Morphology of Neutrophil
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?